NRNP 6665 Week 11 Final Exam STUDY
Questions and Answers 100% CORRECT
1.Question:
Christine is a 9-year-old female who presents for care after
having been placed in the local foster care system. She has been
in and out of foster care for the last 4 years after her parents
were killed in an automobile accident. Christine has been placed
in a variety of homes and residential care facilities. The PMHNP
recognizes that Christine is at high risk for:: A. Dissociative
disorders
B. Post-traumatic stress disorder
C. Impulse-control disorder
D. Attachment disorder
2.Question :
Caylee is a 5-year-old girl who is referred for evaluation by child
protective services. She was recently removed from her
,biological family and placed in foster care, as her home
environment was reportedly unsafe due to conditions of extreme
neglect. Her foster mother reports that Caylee is very quiet and
withdrawn and always appears sad and disinterested in her
surroundings; however, she becomes very irritable when
anything unexpected or unplanned occurs. The foster mother
became very concerned when it appeared that Caylee was
hallucinating. The PMHNP considers that:: A. Caylee is at high risk
for suicide and precautions should be taken
B. The hallucinations are consistent with brief psychotic disorder or
schizophrenia
C. The history and reported symptoms are typical of depressive disorder
in young children
D. This is a common situation when prepubertal children are removed
from the biological parents regardless of how dysfunctional they are
3.Question :
Debi is a 15-year-old girl who is currently being treated for
depression. Her parents have been very proactive and involved
in her care, and Debi has achieved remission 2 months after
beginning treatment with a combination of pharmacotherapy
and cognitive behavioral therapy. While counseling Debi's
parents about important issues in management, the PMHNP
advises that:: A. There is a > 50% likelihood that Debi's younger
sibling will develop depressive symptoms
,B. The mean length of major depressive episode in adolescents is 4
months
C. 20 to 40% of adolescents who have major depressive disorder will
develop bipolar I within 5 years
D. Adolescent-onset depression typically need long-term pharmacologic
manage- ment to prevent relapses
4.Agomelatine: Brand: Valdoxan
-Melatonin multimodal (Mel-MM)
, -Agonist at melatonergic 1 and melatonergic 2 receptors
-Antagonist at 5HT2C receptors
-Not FDA approved: Rx for Depression, Generalized anxiety disorder
-Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/day
at bedtime
5.Amitriptyline (Elavil): Tricyclic antidepressant.
6.Aripiprazole (Abilify): Treatment for depression. Atypical
antipsychotic. "Dopamine stabilizer". Dopamine receptor antagonist in
high concentration and also stimulates increase of dopamine in low
concentrations. Side effects: insomnia, akathisia.
7.Brexpiprazole (Rexulti): Treatment for depression. Atypical
antipsychotic
8.Bupropion (Wellbutrin): Antidepressant and smoking cessation aid,
It can treat depression and help people quit smoking. It can also
prevent depression caused by seasonal affective disorder (SAD).
9.Citalopram (Celexa): Antidepressant, SSRI: 20-40 mg qd.
10.Clomipramine (Anafranil): -Serotonin reuptake inhibitor (S-RI)
-Tricyclic antidepressant (TCA)
-Parent drug is a potent serotonin reuptake inhibitor
Active metabolite is a potent norepinephrine/noradrenaline reuptake
inhibitor
Questions and Answers 100% CORRECT
1.Question:
Christine is a 9-year-old female who presents for care after
having been placed in the local foster care system. She has been
in and out of foster care for the last 4 years after her parents
were killed in an automobile accident. Christine has been placed
in a variety of homes and residential care facilities. The PMHNP
recognizes that Christine is at high risk for:: A. Dissociative
disorders
B. Post-traumatic stress disorder
C. Impulse-control disorder
D. Attachment disorder
2.Question :
Caylee is a 5-year-old girl who is referred for evaluation by child
protective services. She was recently removed from her
,biological family and placed in foster care, as her home
environment was reportedly unsafe due to conditions of extreme
neglect. Her foster mother reports that Caylee is very quiet and
withdrawn and always appears sad and disinterested in her
surroundings; however, she becomes very irritable when
anything unexpected or unplanned occurs. The foster mother
became very concerned when it appeared that Caylee was
hallucinating. The PMHNP considers that:: A. Caylee is at high risk
for suicide and precautions should be taken
B. The hallucinations are consistent with brief psychotic disorder or
schizophrenia
C. The history and reported symptoms are typical of depressive disorder
in young children
D. This is a common situation when prepubertal children are removed
from the biological parents regardless of how dysfunctional they are
3.Question :
Debi is a 15-year-old girl who is currently being treated for
depression. Her parents have been very proactive and involved
in her care, and Debi has achieved remission 2 months after
beginning treatment with a combination of pharmacotherapy
and cognitive behavioral therapy. While counseling Debi's
parents about important issues in management, the PMHNP
advises that:: A. There is a > 50% likelihood that Debi's younger
sibling will develop depressive symptoms
,B. The mean length of major depressive episode in adolescents is 4
months
C. 20 to 40% of adolescents who have major depressive disorder will
develop bipolar I within 5 years
D. Adolescent-onset depression typically need long-term pharmacologic
manage- ment to prevent relapses
4.Agomelatine: Brand: Valdoxan
-Melatonin multimodal (Mel-MM)
, -Agonist at melatonergic 1 and melatonergic 2 receptors
-Antagonist at 5HT2C receptors
-Not FDA approved: Rx for Depression, Generalized anxiety disorder
-Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/day
at bedtime
5.Amitriptyline (Elavil): Tricyclic antidepressant.
6.Aripiprazole (Abilify): Treatment for depression. Atypical
antipsychotic. "Dopamine stabilizer". Dopamine receptor antagonist in
high concentration and also stimulates increase of dopamine in low
concentrations. Side effects: insomnia, akathisia.
7.Brexpiprazole (Rexulti): Treatment for depression. Atypical
antipsychotic
8.Bupropion (Wellbutrin): Antidepressant and smoking cessation aid,
It can treat depression and help people quit smoking. It can also
prevent depression caused by seasonal affective disorder (SAD).
9.Citalopram (Celexa): Antidepressant, SSRI: 20-40 mg qd.
10.Clomipramine (Anafranil): -Serotonin reuptake inhibitor (S-RI)
-Tricyclic antidepressant (TCA)
-Parent drug is a potent serotonin reuptake inhibitor
Active metabolite is a potent norepinephrine/noradrenaline reuptake
inhibitor
